Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism

Thrombosis and Haemostasis

Volumn 111, Issue 3, 2014, Pages 518-530

  Dashty, Monireh ^a,b   Motazacker, Mohammad M ^c   Levels, Johannes ^c   de Vries, Marcel ^a   Mahmoudi, Morteza ^d,e   Peppelenbosch, Maikel P ^b   Rezaee, Farhad ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial peptides; ApoAV; Apolipoproteins; Atherothrombosis; Cathepcin D; CD14; CETP; Coagulation; Dermicidin; LCAT; Lipopolysaccharide binding protein; Lysozyme C; nLC MS MS; PLTP; Prenylcysteine oxidase; Protein S; Proteomics; Prothrombin; TFPI 1

Indexed keywords

APOLIPOPROTEIN; CATHELICIDIN; CATHEPSIN D; DERMCIDIN; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEOME; PROTHROMBIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BIOINFORMATICS; BLOOD CLOTTING; CONTROLLED STUDY; DNA FRAGMENTATION; GENE SEQUENCE; HEMOSTASIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INNATE IMMUNITY; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ULTRACENTRIFUGATION;

ANTI-MICROBIAL PEPTIDES; APOAV; APOLIPOPROTEINS; ATHEROTHROMBOSIS; CATHEPCIN D; CD14; CETP; COAGULATION; DERMICIDIN; LCAT; LIPOPOLYSACCHARIDE BINDING PROTEIN; LYSOZYME C; NLC-MS/MS; PLTP; PRENYLCYSTEINE OXIDASE; PROTEIN S; PROTEOMICS; PROTHROMBIN; TFPI-1;

ANTIGENS, CD14; ANTIMICROBIAL CATIONIC PEPTIDES; APOLIPOPROTEINS A; ATHEROSCLEROSIS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; CARBON-SULFUR LYASES; CATHEPSIN D; CHOLESTEROL ESTER TRANSFER PROTEINS; COMPUTATIONAL BIOLOGY; DYSLIPIDEMIAS; HUMANS; LIPID METABOLISM; LIPOPROTEINS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MASS SPECTROMETRY; MURAMIDASE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEINS; PLASMA; PROTEIN S; PROTEOME; PROTHROMBIN;

EID: 84897076037     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-02-0178     Document Type: Article

References (41)

1. Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA-and ApoB-containing lipoprotein families. Prog Lipid Res 1991; 30: 105-138.
2. Campos H, Perlov D, Khoo C, et al. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolaemia and hypertriglyceridemia. J Lipid Res 2001; 42: 1239-1249.
3. Dashti M, Kulik W, Hoek F, et al. A phospholipidomic analysis of all defined human plasma lipoproteins. Sci Rep 2011; 1: 139.
4. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982; 23: 97-104.
5. Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003; 144: 2201-2207.
6. Queiroz KC, Tio RA, Zeebregts CJ, et al. Human plasma very low density lipoprotein carries Indian hedgehog. J Proteome Res 2010; 9: 6052-6059.
7. Rezaee F, Casetta B, Levels JH, et al. Proteomic analysis of high-density lipoprotein. Proteomics 2006; 6: 721-730.
8. Fredrickson DS, Lees RS. A system for phenotyping hyperlipoproteinemia. Circulation 1965; 31: 321-327.
9. Thompson GR. Management of dyslipidaemia. Heart 2004; 90: 949-955.
10. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707-727.
11. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89: 331-340.
12. Lagrost L, Gambert P, Lallemant C. Combined Effects of Lipid Transfers and Lipolysis on Gradient Gel Patterns of Human Plasma LDL. Arterioscler Thromb Vasc Biol 1994; 14: 1327-1336.
13. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 2002; 43: 1997-2006.
14. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81: 7B-12B.
15. Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007; 115: 450-458.
16. Adiels M, Olofsson SO, Taskinen MR, et al. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28: 1225-1236.
17. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005; 96: 1221-1232.
18. Azzam KM, Fessler MB. Crosstalk between reverse cholesterol transport and innate immunity. Trends Endocrinol Metab 2012; 23: 169-178.
19. Willeit J, Kiechl S, Oberhollenzer F, et al. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol 2000; 20: 529-537.
20. Moyer MP, Tracy RP, Tracy PB, et al. Plasma Lipoproteins Support Prothrombinase and Other Procoagulant Enzymatic Complexes. Arterioscler Thromb Vasc Biol 1998; 18: 458-465.
21. Rota S, McWilliam NA, Baglin TP, et al. Atherogenic Lipoproteins Support Assembly of the Prothrombinase Complex and Thrombin Generation: Modulation by Oxidation and Vitamin E. Blood 1998; 91: 508-515.
22. Griffin JH, Kojima K, Banka CL, et al. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest 1999; 103: 219-227.
23. Kleinveld HA, Duif PF, Pekelharing HL, et al. Oxidation of lipoprotein (a) and low density lipoprotein containing density gradient ultracentrifugation fractions. Biochim Biophys Acta 1996; 1303: 15-21.
24. Levels JH, Bleijlevens B, Rezaee F, et al. SELDI-TOF mass spectrometry of High-Density Lipoprotein. Proteome Sci 2007; 5: 15.
25. Cham BE, Knowles BR. A solvent system for delipidation of plasma or serum without protein precipitation. J Lipid Res 1976; 17: 176-181.
26. Meijer K, de Vries M, Al-Lahham S, et al. Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One 2011; 6: e17154.
27. Zhang J, Xin L, Shan B, et al. PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification. Mol Cell Proteomics 2012; 11: M111 010587.
28. Xie C, Mao X, Huang J, et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res 2011; 39: W316-W322.
29. Salvayre R, Auge N, Benoist H, et al. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 2002; 1585: 213-221.
30. Zapf S, Loos M. Effect of EDTA and citrate on the functional activity of the first component of complement, C1, and the C1q subcomponent. Immunobiology 1985; 170: 123-132.
31. Golanski J, Pietrucha T, Baj Z, et al. Molecular insights into the anticoagulantinduced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. Thromb Res 1996; 83: 199-216.
32. Yang L, Manithody C, Rezaie AR. Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases. Blood 2004; 10: 1753-1759.
33. Karlsson H, Leanderson P, Tagesson C, et al. Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2005; 5: 551-565.
34. Mancone C, Amicone L, Fimia GM, et al. Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDITOF/ TOF. Proteomics 2007; 7: 143-154.
35. Sun HY, Chen SF, Lai MD, et al. Comparative proteomic profiling of plasma very-low-density and low-density lipoproteins. Clin Chim Acta 2010; 411: 336-344.
36. Egusa G, Beltz WF, Grundy SM, et al. Influence of obesity on the metabolism of apolipoprotein B in humans. J Clin Invest 1985; 76: 596-603.
37. Fuhrman B, Volkova N, Aviram M. Paraoxonase 1 (PON1) is present in postprandial chylomicrons. Atherosclerosis 2005; 180: 55-61.
38. Deakin S, Moren X, James RW. Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells. Atherosclerosis 2005; 179: 17-25.
39. O'Brien PJ, Alborn WE, Sloan JH, et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 2005; 51: 351-359.
40. Wang X, Driscoll DM, Morton RE. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F. J Biol Chem 1999; 274: 1814-1820.
41. Dennis MW, Downey C, Brufatto N, et al. Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein. Thromb Haemost 2004; 91: 522-530.